Marshall Wace’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Marshall Wace’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-105,619	Closed	-$4.56M	–	1239
2015 Q3	$4.56M	Buy	105,619 +100,288	+1,881%	+$4.23M	0.06%	307
2015 Q2	$225K	Buy	+5,331	New	+$225K	﹤0.01%	806
2015 Q1	–	Sell	-134,301	Closed	-$4.52M	–	1049
2014 Q4	$4.52M	Sell	134,301 -69,333	-34%	-$2.45M	0.06%	327
2014 Q3	$7.13M	Buy	203,634 +52,956	+35%	+$1.82M	0.1%	232
2014 Q2	$4.95M	Buy	150,678 +133,444	+774%	+$4.57M	0.07%	268
2014 Q1	$635K	Buy	+17,234	New	+$632K	0.01%	546

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Marshall Wace's WX Position: Q4 2015 in Review

Marshall Wace sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 105,619 shares — an estimated $4.56M sold.

Marshall Wace first reported a position in WX in Q1 2014 and held it in 6 quarters. The position peaked at $7.13M in Q3 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Marshall Wace reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Marshall Wace sold 105,619 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.56M.
Marshall Wace first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 6 quarters.
Marshall Wace's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.13M in Q3 2014.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.